Herpes Zoster-Induced Ogilvie’s Syndrome

Table 2

Edelman et al. [7]
Gender	(i) Male,
	(ii) Female,
Age	(i) Range = 32–87 years
	(ii) Mean = 61 years
Comorbidities	(i) Percentage = 45% of patients
	(ii) Malignancies (28%),
	(iii) Arterial hypertension
	(iv) Immunosuppression from
	(a) Eczema
	(b) Transplant
	(c) HIV
Onset of rash	(i) 1 day–several weeks after intestinal symptoms = 48% ()
	(ii) 2 days–one month before intestinal symptoms = 28% ()
	(iii) Simultaneous occurrence = 24% ()
Treatment	(i) Surgical intervention = 17% () [5, 7–10]
	(ii) Conservative management = 83% ()
	(iii) Colonoscopic decompression ()
	(iv) Rectal tube placement ()
Antiviral therapy	(i) Prescribed for 24% ()
	(ii) Successful response reported = none